Scinovex
editorial Open AccessTop 1% cited

Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?

Frontiers in Pharmacology · 2018 · Vol. 9 · pp. 245–245
Kulmira NurgaliR. Thomas JagoeRaquel Abalo

Abstract

The side-effects and long-term sequelae of anti-cancer chemotherapy remain a major source of concern for both patients and clinicians despite the improved efficacy and enhanced survival offered by modern treatments. Current drugs or other approaches to counteract chemotherapyinduced adverse effects are often incompletely effective, frequently do not address potential longerterm sequelae or may even induce other side-effects which only add to patient discomfort. New approaches to improve tolerance and reduce sequelae of cancer chemotherapy are urgently needed and the present Research Topic focuses on this issue and highlights several areas of progress.

Cancer therapeutics and mechanismsPARP inhibition in cancer therapyCancer-related cognitive impairment studiesMedicineCancer chemotherapyAdverse effectCancer drugsChemotherapyCancerPharmacologyClinical pharmacologyIntensive care medicineInternal medicine

Funding

  • Jewish General Hospital
  • Fondation de l'Hôpital général juif
Citations
993
FWCI
31.00
field-weighted impact
References
5
Percentile
100%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae? · Scinovex